Cipla Q1 consolidated net profit at ₹1291.61 crore rises 10%: Stock gains 3%
Cipla consolidated net profit for the quarter ending June 2025 at ₹ 1291.61 crore increased 10% compared to ₹ 1,175.46 crore in the year-ago quarter.
The company's revenue from operations stood at ₹ 6,957.47 crore during Q1, compared to ₹ 6,693.94 crore in the same period last year.
The reported earnings before interest, tax, depreciation, and amortization, or EBITDA, at ₹ 1778 crore grew 4% year-on-year.
The domestic sales, or One India sales, for Cipla contributed more than two-fifths overall at ₹ 3070 crore, growing 6% year on year. The company said that it successfully launched Voltido Trio, its flagship addition to the respiratory portfolio.
The US sales for Cipla in dollar terms stood at $229 million. The US contributed around 28% to overall sales of Cipla. The company had reported $221 million in revenues in the previous quarter and $251 million in the year-ago quarter. The company, though, is maintaining its rate. In the US, however, growth remains challenging due to higher competition in large generic products, like Revlimid, a medication used to treat multiple myeloma.
The company said that its respiratory product Albuterol ranked No. 1 in the market (it supplied more than 50 million+ inhaler units to the U.S. market cumulatively)
The hormonal treatment drug Lanreotide's market share increased to 21% during the quarter. CipLa also launched key assets Nano Paclitaxel (ANDA) and Nilotinib (NDA), strengthening its oncology portfolio. It signed an agreement to launch the first biosimilar product for Cipla in the US. The launch is expected in Q2 FY26.
All this keeps outlook positive for the US sales even though US
The African sales contributing 13% to overall revenues remain another growth driver. The One Africa: Growth momentum during the June quarter was decent, with overall revenue growth at 11% YoY in dollar terms to $102 million. The company said that the private market is growing 1.5 times faster. This is positive since private market sales command higher margins.
Cipla share price, which was trading flat to negative during the first half of the trading session, gained almost 3% to intraday highs of ₹ 1539.75 levels post Q1 results.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
a day ago
- Mint
Stocks to buy for short term: From Apollo Hospitals to Godrej Consumer— Ajit Mishra of Religare Broking suggests 3 names
Stocks to buy for the short term: The Indian stock market witnessed volatile swings on the monthly expiry day and ended marginally lower amid mixed cues. While US President Donald Trump's surprise 25 per cent tariff announcement on India initially triggered a knee-jerk reaction, a gradual recovery in heavyweight stocks across sectors helped the market briefly turn positive and end with mild losses. The Nifty 50 ended 0.35 per cent lower at 24,768.35 on Thursday, July 31. Ajit Mishra, SVP of research at Religare Broking, pointed out that as the August derivatives series begins, the market is likely to consolidate, but global developments and corporate earnings will continue to drive volatility. "We maintain our cautious stance and recommend a stock-specific approach, given the mixed trends across sectors. Traders should also avoid averaging down on loss-making positions," said Mishra. Mishra suggests buying shares of Apollo Hospitals, Cipla, and Godrej Consumer Products for the short term. Mishra underscored that Apollo Hospitals continues to demonstrate a structurally strong uptrend on the weekly chart, with the price maintaining its position well above the 100-week EMA. After a prolonged steady uptrend phase, the stock witnessed a corrective decline, finding support near the long-term moving average. This correction was followed by a sharp V-shaped recovery, reinforcing bullish sentiment. The stock is now trading near its all-time highs, consolidating in a tight range—a healthy sign, indicating strength and possible continuation. The rising trend line from recent lows remains intact, supporting the current price action. "Volume patterns are relatively stable, and any breakout above the recent highs could lead to the next leg of the rally. Overall, the structure favours bullish continuation with immediate support near ₹ 7,200 and the 100 WEMA acting as a long-term cushion," said Mishra. Apollo Hospitals Enterprise technical chart Mishra highlighted that Cipla has exhibited a classic technical progression marked by a strong base formation followed by a robust rally, reflecting underlying institutional accumulation. Post this rally, the stock entered a prolonged consolidation phase between ₹ 1,400– ₹ 1,575, indicating a healthy pause within a primary uptrend. This rectangle pattern near the highs reflects time-wise correction rather than price damage, suggesting strength in structure. The breakout from this range, supported by a bullish candle and pickup in volume, signals a potential resumption of the broader trend. "Price continues to trade above key moving averages, which are aligned positively, reinforcing bullish sentiment. The breakout zone near ₹ 1,525 now becomes immediate support, while the stock eyes a potential move toward ₹ 1,675– ₹ 1,740 zone," said Mishra. Cipla technical chart According to Mishra, Godrej Consumer has exhibited a strong upward rally in the past, followed by a broad consolidation phase, which resembles a trend continuation pattern. "After peaking near ₹ 1,500, the stock retraced and found demand around the 200-week EMA zone near ₹ 1,080, where it formed a base. Since then, price action has turned range bound between ₹ 1,100– ₹ 1,300, forming a rectangular consolidation on the weekly chart," Mishra observed. "The long-term EMA continues to slope upward, confirming that the broader trend remains bullish. On the downside, the ₹ 1,080– ₹ 1,100 zone will act as a strong support area, with immediate support around 1190. The fresh buoyancy in the FMCG pack is added positively," Mishra said. Godrej Consumer Products technical chart Read all market-related news here Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of the expert or broking firm, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
Mint
2 days ago
- Mint
Stock Market Today LIVE Updates: Sensex crashes over 500 points, Nifty 50 around 24,700 after Trump tariffs
31 Jul 2025, 11:40 AM IST Stock Market Today LIVE: FMCG stocks outperformed in an otherwise weak market on Thursday, buoyed by HUL Q1 results. Shares of Hindustan Unilever, Godrej Consumer Products, Emami, United Spirits, Dabur, Marico, Britannia Industries, and ITC were among the top gainers in the Nifty FMCG index, each rising over 1%. 31 Jul 2025, 11:33 AM IST Stock Market Today LIVE: Indian stock market benchmark indices, Sensex and Nifty 50, rebounded from day's low levels, but were still trading in the red. The Sensex was down over 200 points as against more than 700 point-loss at the opening, and the benchmark Nifty 50 near 24,800 level. 31 Jul 2025, 11:18 AM IST Stock Market Today LIVE: Shares of Indian seafood exporters declined sharply on Thursday following the announcement of new tariffs by US President Donald Trump. Stocks such as Avanti Feeds, Apex Frozen Foods, Zeal Aqua, and Waterbase fell over 6% after the US imposed a 25% tariff on Indian exports. Avanti Feeds share price slipped as much as 6.62%, while Apex Frozen Foods declined 6.48%. Zeal Aqua shares fell 4.05%, and Waterbase was down 4.45% on the BSE. 31 Jul 2025, 10:53 AM IST Stock Market Today LIVE: The US tariff will have little impact on India's 2HFY26E earnings recovery trajectory, as high-weightage sectors such as financials, consumption, and technology are unaffected. There may be a short-term selloff as the markets are already fragile with weak earnings momentum (1QFY26 numbers are tepid) and little valuation comfort, with most indices trading at LTA+ PER. The main sectors that are affected are textiles, auto ancillaries, chemicals and, possibly, OMCs, if Russian crude imports are stopped, said Madhavi Arora, Lead – Economist at Emkay Global Financial Services Ltd. There are potential risks to pharma and EMS if the current exemptions are terminated in the new 25%+ regime (not known yet). We believe the 25%+ regime is the worst-case scenario and the final bilateral deal could be reached with a lower tariff. In any case, a meaningful correction is an opportunity to buy the market with consumer discretionary and industrials as the key sectors, she added. 31 Jul 2025, 10:31 AM IST Stock Market Today LIVE: Indian stock market has partially discounted US tariffs announcement by underperforming the global peers over past few weeks, and markets will attempt to recover from these initial losses as the day progresses. Today's monthly derivative expiry may add another layer of volatility to trading, said Devarsh Vakil, Head of Prime Research at HDFC Securities. According to him, recent swing lows of 24,598 and 24,473 could now act as immediate support levels. On the higher side, the band of 24,900 - 25,000 would continue to serve as a substantial hurdle for the Nifty 50, indicating resistance for any upward moves. 31 Jul 2025, 10:06 AM IST Stock Market Today LIVE: Mixed Wall Street cues, countdown to August 1st tariff deadline and Fed meet, FPI outflows may continue to dominate trade setup on Dalal Street. Participants may gradually build positions over next few days as fresh series post July expiry may prove to be rewarding as large part of FED meet and tariff uncertainty may get over by the end of the week, said Vikram Kasat, Head - Advisory, PL Capital. 31 Jul 2025, 09:45 AM IST Stock Market Today LIVE: A ten-fold rise in tariffs will be a drag on growth, to the extent of 20-30 bps. But, it would be a mistake to extrapolate the announced tariffs to eternity. We expect a trade deal in the next 6 months leading to reductions in the rate of tariffs, maybe in the region of 15%. Meanwhile, do expect a small cut to EPS estimates of major indices as the correlation of GDP growth and corporate profitability is highest for India vs. peers, said Jyoti Prakash, Managing Partner, Equity and PMS at AlphaaMoney 31 Jul 2025, 09:33 AM IST Stock Market Today LIVE: Dr Reddy's Laboratories, Reliance Industries, Bharti Airtel, M&M and Adani Enterprises were the top losers among the Nifty 50 constituents. On the other hand, Jio Financial Services, Eternal, PowerGrid Corporation of India JSW Steel and SBI Life Insurance Company were the top gainers. 31 Jul 2025, 09:29 AM IST Stock Market Today LIVE: There is a short-term hit to Indian exports and GDP growth from 25% tariff on India by the US. This short-term hit will reflect in the stock market, too, in the short-term. From the investor perspective it is important to understand that the 25% tariff will come down after the negotiations which start in mid-August. The 25% tariff imposed on India is far higher than the rates reached in trade deals with other countries. This is the typical Trumpian strategy to get better deals from India in other areas and finally settle at a tariff rate around 20% or less, said Dr. VK Vijayakumar, Chief Investment Strategist, Geojit Investments Limited. Nifty 50 is unlikely to go below the support level of 24,500. Investors can buy the dip focusing on domestic consumption themes, particularly segments like leading private sector banking names, telecom, capital goods, cement, hotels and select autos which have done well in Q1, he added. 31 Jul 2025, 09:21 AM IST Stock Market Today LIVE: Broader market slipped, in line with the benchmark indices Sensex and Nifty 50. The Nifty Midcap 100 and the Nifty Smallcap 100 indices traded 1.1% lower each. All the sectoral indices traded in the red, with the Nifty Pharma, Nifty Auto, Nifty Realty, Nifty Oil & Gas sectors declining over a percent each. 31 Jul 2025, 09:16 AM IST Stock Market Today LIVE: Indian stock market opened sharply lower on Thursday after US President Donald Trump announced 25% tariffs on Indian goods. Sensex crashed 786.36 points, or 0.97%, lower at 80,695.50, while the Nifty 50 opened 212.80 points, or 0.86%, lower at 24,642.25. Bank Nifty index opened 422.55 points, or 0.75%, lower at 55,728.15. 31 Jul 2025, 08:50 AM IST Stock Market Today LIVE: Asian markets traded mixed on Thursday as investors assessed Bank of Japan's policy decision to hold interest rates. Japan's Nikkei 225 rallied 0.90% and the Topix index gained 0.3%. South Korea's Kospi index fell 0.06%, while Hong Kong's Hang Seng index declined 0.9%. 31 Jul 2025, 08:47 AM IST Stock Market Today LIVE: US stock market ended Wednesday's choppy session mixed, after the Federal Reserve kept the interest rate unchanged and as Chair Jerome Powell dampened expectations of a rate cut in the September meeting. The Dow Jones Industrial Average declined 171.71 points, or 0.38%, to 44,461.28, while the S&P 500 fell 7.96 points, or 0.12%, to 6,362.90. The Nasdaq Composite closed 31.38 points, or 0.15%, higher at 21,129.67. 31 Jul 2025, 08:41 AM IST Stock Market Today LIVE: Gift Nifty was trading around 24,682 level, a discount of nearly 187 points from the Nifty futures' previous close, indicating a gap-down start for the Indian stock market indices. 31 Jul 2025, 08:39 AM IST Stock Market Today LIVE: The Indian stock market is expected to open sharply lower on Thursday, 31 July 2025, after the US President Donald Trump announced a 25% tariff on Indian goods. The trends on Gift Nifty also indicate a gap-down start for the Indian benchmark indices, Sensex and Nifty 50.
Time of India
2 days ago
- Time of India
Cipla Share Price Live Updates: Cipla's Volatility Metrics
31 Jul 2025 | 08:58:55 AM IST Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Cipla, including: Last traded price 1559.4, Market capitalization: 125967.49, Volume: 1390012, Price-to-earnings ratio 23.36, Earnings per share 66.76. Get a complete picture of Cipla's performance through our comprehensive blend of fundamental and technical indicators. Stay informed about breaking news that can influence the stock's trajectory. Our liveblog equips you with the knowledge and insights needed to make confident investment decisions. Don't miss out on the latest updates as Cipla continues to make waves in the market. The data points are updated as on 08:58:55 AM IST, 31 Jul 2025 Show more
